Cleared Traditional

K770948 - LIPOPROTEIN PROFILING SYSTEM

K770948 is an FDA 510(k) clearance for LIPOPROTEIN PROFILING SYSTEM, manufactured by Beckman Instruments, Inc.. The device is a Class 1 Chemistry device with product code JHL cleared through the Traditional 510(k) pathway after a 51-day FDA review.

K770948 · Beckman Instruments, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1977
Decision
51d
Days
Class 1
Risk

K770948 is an FDA 510(k) clearance for the LIPOPROTEIN PROFILING SYSTEM. Classified as Microdensitometry Method, Lipoproteins (product code JHL), Class I - General Controls.

Submitted by Beckman Instruments, Inc. (Mchenry, US). The FDA issued a Cleared decision on July 15, 1977 after a review of 51 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1475 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Beckman Instruments, Inc. devices

FDA 510(k) Submission Details - K770948

510(k) Number K770948 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 25, 1977
Decision Date July 15, 1977
Days to Decision 51 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 88d · This submission: 51d
Pathway characteristics
Predicate-based equivalence.

JHL Device Classification - Class 1, General Controls

Product Code JHL Microdensitometry Method, Lipoproteins
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1475
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.